Dr. Prakriti Singh

Consultant

Medical Oncology

Experience: 7 Years

About

Dr. Prakriti Singh is a dedicated and compassionate Medical Oncologist with strong academic training and clinical experience in comprehensive cancer care. She specializes in the diagnosis and treatment of a wide range of malignancies using evidence-based therapies. Her expertise includes chemotherapy, immunotherapy, and targeted therapy, along with the management of treatment-related complications.

Dr. Singh has a special interest in female oncology, particularly breast and gynecological cancers. She is also actively involved in cancer prevention, early detection, and awareness programs to promote timely screening and improve patient outcomes.

With a patient-centric and multidisciplinary approach, Dr. Prakriti Singh is committed to delivering personalized cancer care and improving the quality of life of her patients.

Medical Registration

MP-22197

Education

MBBS – Kasturba Medical College (KMC), Mangalore – 2014
MD (Radiation Oncology) – Gandhi Medical College, Bhopal
DrNB (Medical Oncology) – Asian Institute of Medical Sciences, Faridabad

Experience

Academic Junior Resident, Gandhi Medical College, Bhopal
Senior Resident, Gandhi Medical College, Bhopal
Senior Resident, Asian Institute of Medical Sciences, Faridabad

Area Of Interest

Precision Oncology
Targeted Therapy
Immunotherapy
Molecular Oncology
Chemotherapy in Solid Tumors (Breast, Lung, Gastrointestinal, Genitourinary, Head & Neck, Sarcoma)
Cancer Screening and Preventive Oncology
Cancer Vaccination and Awareness Programs

Membership

ESMO – European Society for Medical Oncology
ISMPO – Indian Society of Medical & Paediatric Oncology

Research And Publication

E-Poster- acceptance on topic A prospective study for assessing ventilation-perfusion ratio (V/Q) , and its effect on response, prognosis and treatment related toxicity in lung cancer in ESMO Asia 2025
Conference abstract- A. Badola, P. Singh, S. Anand, V. Sekar, J. Verma, 321P Epidemiology and survival analysis of epithelial ovarian cancer: Results from comprehensive care center in north India, Annals of Oncology, Volume 34, Supplement 4,2023, Page S1596
V. Sekar, A. Badola, S. Anand, A.K. Zaidi, J. Verma, P. Singh, D. Das, C. Lalrindiki, D.L. Nongrum, J. L,163P Chemotherapy versus palliative radiotherapy in advanced inoperable gall bladder cancer, Annals of Oncology, Volume 34, Supplement 4,2023, Page S1539
Badola A, Bansal P, Mehta P, Malhotra M, Cheemala SC, Sood S, Anand S, Sekar V, Singh P, Verma J, Zaidi A. 61P Next generation sequencing and its clinical utility in advanced cancer: Single institute experience from low-middle income country. Annals of Oncology. 2023 Oct 1;34:S205